1J5 — Hyphens Pharma International Cashflow Statement
0.000.00%
Last trade - 00:00- SG$83.48m
- SG$69.72m
- SG$170.60m
- 61
- 77
- 71
- 85
Annual cashflow statement for Hyphens Pharma International, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 7.99 | 7.11 | 8.26 | 14.3 | 10.6 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -0.068 | -0.188 | 0.457 | -0.127 | -0.878 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.471 | -4.87 | -4.88 | -0.009 | -6.84 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 9.45 | 4.13 | 6.04 | 16.9 | 5.64 |
| Capital Expenditures | -0.606 | -1.2 | -0.835 | -1.31 | -1.2 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.157 | 0.187 | -14.1 | 0.308 | -0.28 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.449 | -1.01 | -14.9 | -1.01 | -1.48 |
| Financing Cash Flow Items | -0.138 | -0.11 | -0.095 | 5.86 | -0.278 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -5.19 | -1.76 | 0.814 | 1.15 | -17.3 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.81 | 1.36 | -8.06 | 17 | -13.1 |